Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""EVALUATION CRITERIA"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 10990
Tytuł:
Efficacy and safety of temozolomide-based regimens in advanced pancreatic neuroendocrine tumors: a systematic review and meta-analysis.
Autorzy:
Taherifard E; Department of Medicine, Division of Hematology & Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Bakhtiar M; Department of Medicine, Division of Hematology & Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Mahnoor M; Department of Medicine, Division of Hematology & Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Ahmed R; Department of Medicine, Division of Hematology & Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Cavalcante L; Novant Health Cancer Institute, Charlotte, NC, USA.
Zhang J; Department of Medicine, Division of Hematology & Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
Saeed A; Department of Medicine, Division of Hematology & Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. .; UPMC Hillman Cancer Center, Pittsburgh, PA, USA. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Feb 12; Vol. 24 (1), pp. 192. Date of Electronic Publication: 2024 Feb 12.
Typ publikacji:
Meta-Analysis; Systematic Review
MeSH Terms:
Neuroendocrine Tumors*/drug therapy
Neuroendocrine Tumors*/pathology
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/pathology
Neuroectodermal Tumors, Primitive*
Humans ; Temozolomide/adverse effects ; Response Evaluation Criteria in Solid Tumors
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
First-in-human study of GFH018, a small molecule inhibitor of transforming growth factor-β receptor I inhibitor, in patients with advanced solid tumors.
Autorzy:
Guo Y; Department of Medical Oncology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Wang Z; The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Zhou H; The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Pan H; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Han W; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Deng Y; Sixth Affiliated Hospital of Sun Yat-Sen University, Guangdong, China.
Li Q; Department of Medical Oncology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Xue J; Department of Medical Oncology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Ge X; Department of Medical Oncology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Wang S; Clinical Department, GenFleet Therapeutics Inc, Shanghai, China.
Wang J; Translational Science, GenFleet Therapeutics Inc, Shanghai, China.
Zhang Y; Clinical Department, GenFleet Therapeutics Inc, Shanghai, China.
Zhao C; Clinical Department, GenFleet Therapeutics Inc, Shanghai, China.
Zhu H; Clinical Department, GenFleet Therapeutics Inc, Shanghai, China.
Wang Y; Clinical Department, GenFleet Therapeutics Inc, Shanghai, China.
Shen H; Clinical Department, GenFleet Therapeutics Inc, Shanghai, China.
Liu D; Translational Science, GenFleet Therapeutics Inc, Shanghai, China.
Li J; Department of Medical Oncology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Apr 10; Vol. 24 (1), pp. 444. Date of Electronic Publication: 2024 Apr 10.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Neoplasms*/drug therapy
Neoplasms*/pathology
Adult ; Humans ; Response Evaluation Criteria in Solid Tumors ; Transforming Growth Factor beta ; Transforming Growth Factors/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Distinguishing recurrence from radiation-induced lung injury at the time of RECIST progressive disease on post-SABR CT scans using radiomics.
Autorzy:
Dammak S; Baines Imaging Research Laboratory, London Regional Cancer Program, London Health Sciences Centre, Victoria Hospital (A3-123A), 800 Commissioners Rd E, London, ON, N6A 5W9, Canada. .; School of Biomedical Engineering, Western University, London, ON, Canada. .
Gulstene S; Department of Radiation Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
Palma DA; Baines Imaging Research Laboratory, London Regional Cancer Program, London Health Sciences Centre, Victoria Hospital (A3-123A), 800 Commissioners Rd E, London, ON, N6A 5W9, Canada.; Department of Radiation Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
Mattonen SA; Baines Imaging Research Laboratory, London Regional Cancer Program, London Health Sciences Centre, Victoria Hospital (A3-123A), 800 Commissioners Rd E, London, ON, N6A 5W9, Canada.; Department of Medical Biophysics, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
Senan S; Department of Radiation Oncology, VU Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Ward AD; Baines Imaging Research Laboratory, London Regional Cancer Program, London Health Sciences Centre, Victoria Hospital (A3-123A), 800 Commissioners Rd E, London, ON, N6A 5W9, Canada.; Department of Medical Biophysics, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 14; Vol. 14 (1), pp. 3758. Date of Electronic Publication: 2024 Feb 14.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/radiotherapy
Lung Neoplasms*/pathology
Lung Injury*/diagnostic imaging
Lung Injury*/etiology
Radiation Injuries*/etiology
Radiosurgery*/adverse effects
Humans ; Response Evaluation Criteria in Solid Tumors ; Radiomics ; Neoplasm Recurrence, Local/pathology ; Tomography, X-Ray Computed
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
North Dakota Vocational Education Assessment System.
Autorzy:
North Dakota State Board for Vocational Education, Bismarck. Research Coordinating Unit.
North Dakota Univ., Grand Forks. Dept. of Business and Vocational Education.
Pokaż więcej
Deskryptory:
Educational Assessment
Evaluation Criteria
Evaluation Methods
Measurement Instruments
Postsecondary Education
Program Evaluation
Secondary Education
Vocational Education
Recenzowane naukowo:
N
Page Count:
45
Sponsoring Agency:
Bureau of Occupational and Adult Education (DHEW/OE), Washington, DC. Div. of Research and Demonstration.
Szczegóły
Tytuł:
Introduction to HE Higher Education Ranking: Methodology, Criteria, and Indicators
Autorzy:
Mustafa Kayyali
Pokaż więcej
Deskryptory:
Higher Education
Achievement Rating
Reputation
Universities
Institutional Evaluation
Evaluation Methods
Evaluation Criteria
Educational Assessment
Holistic Approach
Institutional Mission
Student Recruitment
Strategic Planning
Resource Allocation
Educational Indicators
Źródło:
Online Submission. 2023.
Recenzowane naukowo:
N
Page Count:
349
Książka
Szczegóły
Tytuł:
Overall survival of patients with hepatocellular carcinoma treated with sintilimab and disease outcome after treatment discontinuation.
Autorzy:
Wang K; Tongji University Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200072, China.; Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, 200433, China.
Xiang YJ; Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, 200433, China.; Department of Hepatobiliary Surgery, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, 325000, China.
Yu HM; Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, 200433, China.
Cheng YQ; Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, 200433, China.
Feng JK; Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, 200433, China.
Liu ZH; Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, 200433, China.
Shan YF; Department of Hepatobiliary Surgery, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, 325000, China.
Zheng YT; Department of Hepatobiliary Surgery, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, 325000, China.
Ni QZ; Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, 200433, China.; CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China.
Cheng SQ; Tongji University Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200072, China. .; Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, 200433, China. .; Department of Hepatobiliary Surgery, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, 325000, China. .; Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200083, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Oct 23; Vol. 23 (1), pp. 1017. Date of Electronic Publication: 2023 Oct 23.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Humans ; Retrospective Studies ; Response Evaluation Criteria in Solid Tumors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
OncoSNIPE® Study Protocol, a study of molecular profiles associated with development of resistance in solid cancer patients.
Autorzy:
Vachenc S; Oncodesign SA, 18-20 rue Jean Mazen, 21079, Dijon Cedex, France. .
Gobbo J; Centre Georges-François Leclerc, 1 rue Professeur Marion, 21079, Dijon Cedex, France. .; Inserm 1231, 8 Boulevard Jeanne d'ARC, 21000, Dijon, France. .
Moujarrebe SE; Oncodesign SA, 18-20 rue Jean Mazen, 21079, Dijon Cedex, France.
Desmoulins I; Centre Georges-François Leclerc, 1 rue Professeur Marion, 21079, Dijon Cedex, France.
Gilabert M; Institut Paoli-Calmettes, 232 Bd de Sainte Marguerite, 13009, Marseille, France.
Beau-Faller M; Hôpitaux Universitaires de Strasbourg, Avenue Molière, 67000, Strasbourg, France.
Mitry E; Institut Paoli-Calmettes, 232 Bd de Sainte Marguerite, 13009, Marseille, France.
Girard N; Institut Curie, 26 Rue d'Ulm, 75005, Paris, France.
Bertaut A; Centre Georges-François Leclerc, 1 rue Professeur Marion, 21079, Dijon Cedex, France.
Dusetti N; Cancer Research Center of Marseille, CRCM, Inserm, CNRS, Paoli-Calmettes Institut, Aix-Marseille University, Marseille, France.
Iovanna JL; Institut Paoli-Calmettes, 232 Bd de Sainte Marguerite, 13009, Marseille, France.; Cancer Research Center of Marseille, CRCM, Inserm, CNRS, Paoli-Calmettes Institut, Aix-Marseille University, Marseille, France.
Yousfi R; Oncodesign SA, 18-20 rue Jean Mazen, 21079, Dijon Cedex, France.
Pierrat F; Acobiom SAS, 1682 rue de la Valsière Cap Delta Biopôle Euromédecine II, 34790, Grables, France.
Bruno R; Acobiom SAS, 1682 rue de la Valsière Cap Delta Biopôle Euromédecine II, 34790, Grables, France.
Cueff A; Centre Georges-François Leclerc, 1 rue Professeur Marion, 21079, Dijon Cedex, France.
Boidot R; Centre Georges-François Leclerc, 1 rue Professeur Marion, 21079, Dijon Cedex, France.
Genne P; Oncodesign SA, 18-20 rue Jean Mazen, 21079, Dijon Cedex, France.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2022 Jan 06; Vol. 22 (1), pp. 41. Date of Electronic Publication: 2022 Jan 06.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Neoplasms*/pathology
Neoplasms*/therapy
Response Evaluation Criteria in Solid Tumors*
Adult ; Female ; Humans ; Male ; Biomarkers, Tumor/analysis ; Breast Neoplasms/pathology ; Breast Neoplasms/therapy ; Carcinoma, Non-Small-Cell Lung/pathology ; Carcinoma, Non-Small-Cell Lung/therapy ; Carcinoma, Pancreatic Ductal/pathology ; Carcinoma, Pancreatic Ductal/therapy ; Disease Resistance ; Drug Resistance, Neoplasm ; Lung Neoplasms/pathology ; Lung Neoplasms/therapy ; Pancreatic Neoplasms/pathology ; Pancreatic Neoplasms/therapy ; Triple Negative Breast Neoplasms/pathology ; Triple Negative Breast Neoplasms/therapy ; Multicenter Studies as Topic ; Clinical Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Is response evaluation criteria in solid tumors (RECIST) effective in patient selection for radical resection after neoadjuvant immunotherapy with advanced NSCLC?
Autorzy:
Xu Y; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Ma D; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Qin Y; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Li S; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Li J; Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Jiang Y; Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Wang M; Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Xu Y; Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Zhao J; Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Chen M; Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Cheng W; Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Hu K; Department of Radiotherapy, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Liu H; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2023 Jun; Vol. 14 (17), pp. 1635-1639. Date of Electronic Publication: 2023 Apr 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/pathology
Carcinoma, Squamous Cell*
Humans ; Response Evaluation Criteria in Solid Tumors ; Neoadjuvant Therapy/methods ; Patient Selection ; Immunotherapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Tumor response as defined by iRECIST in gastrointestinal malignancies treated with PD-1 and PD-L1 inhibitors and correlation with survival.
Autorzy:
Xie P; Department of Radiology, The Sixth Affiliated Hospital of Sun Yat-sen University, No.26 Yuancunerheng Road, Guangzhou, 510655, Guangdong, China.; Department of Medicine and Department of Biomedical Data Science, The Stanford Center for Biomedical Informatics Research (BMIR), 1265 Welch Rd, Stanford, CA, 94305, USA.
Zheng H; Department of Medicine and Department of Biomedical Data Science, The Stanford Center for Biomedical Informatics Research (BMIR), 1265 Welch Rd, Stanford, CA, 94305, USA.
Chen H; Department of Radiation Oncology, The Sixth Affiliated Hospital of Sun Yat-sen University, No.26 Yuancunerheng Road, Guangzhou, 510655, Guangdong, China.
Wei K; Department of Radiology, The Sixth Affiliated Hospital of Sun Yat-sen University, No.26 Yuancunerheng Road, Guangzhou, 510655, Guangdong, China.
Pan X; Department of Radiology, The Sixth Affiliated Hospital of Sun Yat-sen University, No.26 Yuancunerheng Road, Guangzhou, 510655, Guangdong, China.
Xu Q; Department of Medicine and Department of Biomedical Data Science, The Stanford Center for Biomedical Informatics Research (BMIR), 1265 Welch Rd, Stanford, CA, 94305, USA.; Department of Medical Imaging, Jinling Hospital, Nanjing University School of Medicine, No.305, Zhongshan East Road, Nanjing, 210002, China.
Wang Y; Department of Radiology, The Sixth Affiliated Hospital of Sun Yat-sen University, No.26 Yuancunerheng Road, Guangzhou, 510655, Guangdong, China.
Tang C; Department of Radiology, The Sixth Affiliated Hospital of Sun Yat-sen University, No.26 Yuancunerheng Road, Guangzhou, 510655, Guangdong, China.
Gevaert O; Department of Medicine and Department of Biomedical Data Science, The Stanford Center for Biomedical Informatics Research (BMIR), 1265 Welch Rd, Stanford, CA, 94305, USA. .
Meng X; Department of Radiology, The Sixth Affiliated Hospital of Sun Yat-sen University, No.26 Yuancunerheng Road, Guangzhou, 510655, Guangdong, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2021 Nov 19; Vol. 21 (1), pp. 1246. Date of Electronic Publication: 2021 Nov 19.
Typ publikacji:
Journal Article
MeSH Terms:
Gastrointestinal Neoplasms*/drug therapy
Gastrointestinal Neoplasms*/immunology
Gastrointestinal Neoplasms*/mortality
Gastrointestinal Neoplasms*/pathology
Response Evaluation Criteria in Solid Tumors*
Tumor Burden*/drug effects
Immune Checkpoint Inhibitors/*therapeutic use
Adult ; Age Factors ; Analysis of Variance ; DNA Mismatch Repair ; Female ; Genes, ras ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Evaluating the effect of Neoadjuvant chemotherapy for esophageal Cancer using the RECIST system with shorter-axis measurements: a retrospective multicenter study.
Autorzy:
Taniyama Y; Department of Surgery, Graduate School of Medicine, Tohoku University, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan. .
Murakami K; Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Yoshida N; Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Takahashi K; Department of Surgery, Graduate School of Medicine, Tohoku University, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.; Department of Radiology, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Matsubara H; Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Baba H; Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Kamei T; Department of Surgery, Graduate School of Medicine, Tohoku University, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2021 Sep 09; Vol. 21 (1), pp. 1008. Date of Electronic Publication: 2021 Sep 09.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Response Evaluation Criteria in Solid Tumors*
Adenocarcinoma/*mortality
Chemotherapy, Adjuvant/*mortality
Esophageal Neoplasms/*mortality
Esophageal Squamous Cell Carcinoma/*mortality
Neoadjuvant Therapy/*mortality
Adenocarcinoma/drug therapy ; Adenocarcinoma/pathology ; Aged ; Esophageal Neoplasms/drug therapy ; Esophageal Neoplasms/pathology ; Esophageal Squamous Cell Carcinoma/drug therapy ; Esophageal Squamous Cell Carcinoma/pathology ; Female ; Follow-Up Studies ; Humans ; Male ; Prognosis ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Evaluation of the capability and reproducibility of RECIST 1.1. measurements by technologists in breast cancer follow-up: a pilot study.
Autorzy:
Gouel P; Department of Medical Imaging, Henri Becquerel Cancer Center, Rouen, Normandy, France. .; QuantIF-LITIS EA4108, University of Rouen, Rouen, Normandy, France. .
Callonnec F; Department of Medical Imaging, Henri Becquerel Cancer Center, Rouen, Normandy, France.
Levêque É; Department of Statistics and Clinical Research Unit, Henri Becquerel Cancer Center, Rouen, Normandy, France.
Valet C; Department of Medical Imaging, Henri Becquerel Cancer Center, Rouen, Normandy, France.
Blôt A; Department of Medical Imaging, Henri Becquerel Cancer Center, Rouen, Normandy, France.
Cuvelier C; Department of Medical Imaging, Henri Becquerel Cancer Center, Rouen, Normandy, France.
Saï S; Department of Medical Imaging, Henri Becquerel Cancer Center, Rouen, Normandy, France.
Saunier L; Department of Medical Imaging, Henri Becquerel Cancer Center, Rouen, Normandy, France.
Pepin LF; Department of Statistics and Clinical Research Unit, Henri Becquerel Cancer Center, Rouen, Normandy, France.
Hapdey S; Department of Medical Imaging, Henri Becquerel Cancer Center, Rouen, Normandy, France.; QuantIF-LITIS EA4108, University of Rouen, Rouen, Normandy, France.
Libraire J; Department of Statistics and Clinical Research Unit, Henri Becquerel Cancer Center, Rouen, Normandy, France.
Vera P; Department of Medical Imaging, Henri Becquerel Cancer Center, Rouen, Normandy, France.; QuantIF-LITIS EA4108, University of Rouen, Rouen, Normandy, France.
Viard B; Department of Medical Imaging, Henri Becquerel Cancer Center, Rouen, Normandy, France.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Jun 05; Vol. 13 (1), pp. 9148. Date of Electronic Publication: 2023 Jun 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms*/diagnostic imaging
Humans ; Female ; Response Evaluation Criteria in Solid Tumors ; Pilot Projects ; Reproducibility of Results ; Tomography, X-Ray Computed/methods ; Observer Variation ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer.
Autorzy:
Chen DT; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States of America.
Chan W; Department of Biostatistics and Data Science, School of Public Health, University of Texas Health Science Center at Houston, Houston, Texas, United States of America.
Thompson ZJ; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States of America.
Thapa R; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States of America.
Beg AA; Department of Immunotherapy, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States of America.
Saltos AN; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States of America.
Chiappori AA; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States of America.
Gray JE; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States of America.
Haura EB; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States of America.
Rose TA; Department of Radiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States of America.
Creelan B; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Jul 01; Vol. 16 (7), pp. e0252041. Date of Electronic Publication: 2021 Jul 01 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Response Evaluation Criteria in Solid Tumors*
Carcinoma, Non-Small-Cell Lung/*pathology
Lung Neoplasms/*pathology
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/therapeutic use ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/mortality ; Female ; Humans ; Linear Models ; Lung Neoplasms/drug therapy ; Lung Neoplasms/mortality ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Staging ; Survival Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Native and Non-Native Language Teachers' Perspectives on Teacher Quality Evaluation
Autorzy:
Tajeddin, Zia (ORCID 0000-0002-0430-6408)
Saeedi, Zari (ORCID 0000-0003-2165-8891)
Mozaffari, Hamideh (ORCID 0000-0003-3530-6731)
Pokaż więcej
Deskryptory:
Teacher Evaluation
Teacher Effectiveness
Caring
Classroom Techniques
Video Technology
Evaluation Criteria
Language Teachers
Native Speakers
Second Language Instruction
Second Language Learning
Native Language
Content Analysis
Accuracy
Teacher Attitudes
Teacher Characteristics
Foreign Countries
Peer Evaluation
Private Education
Indo European Languages
Źródło:
TESL-EJ. May 2023 27(1).
Recenzowane naukowo:
Y
Page Count:
26
Czasopismo naukowe
Szczegóły
Tytuł:
Comparison of the Immunotherapy Response Evaluation Criteria in Solid Tumours (iRECIST) with RECIST for capturing treatment response of patients with metastatic urothelial carcinoma treated with pembrolizumab.
Autorzy:
Fukuokaya W; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
Kimura T; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
Yanagisawa T; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
Kimura S; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
Tsuzuki S; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
Koike Y; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.; Department of Urology, Kameda Medical Center, Kamogawa City, Chiba, Japan.
Iwamoto Y; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
Enei Y; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
Tanaka M; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
Urabe F; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
Onuma H; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
Honda M; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
Miki J; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
Oyama Y; Department of Medical Oncology, Kameda Medical Center, Kamogawa City, Chiba, Japan.
Abe H; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.; Department of Urology, Kameda Medical Center, Kamogawa City, Chiba, Japan.
Egawa S; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2021 Jan; Vol. 127 (1), pp. 90-95. Date of Electronic Publication: 2020 Aug 06.
Typ publikacji:
Comparative Study; Journal Article; Multicenter Study
MeSH Terms:
Response Evaluation Criteria in Solid Tumors*
Antibodies, Monoclonal, Humanized/*therapeutic use
Antineoplastic Agents, Immunological/*therapeutic use
Carcinoma, Transitional Cell/*drug therapy
Urinary Bladder Neoplasms/*drug therapy
Aged ; Carcinoma, Transitional Cell/mortality ; Carcinoma, Transitional Cell/secondary ; Disease Progression ; Female ; Humans ; Male ; Organoplatinum Compounds/therapeutic use ; Proportional Hazards Models ; Retreatment ; Retrospective Studies ; Survival Rate ; Urinary Bladder Neoplasms/mortality ; Urinary Bladder Neoplasms/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Validation of International Working Group response criteria in higher-risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium.
Autorzy:
Komrokji RS; Malignant Hematology Department, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Al Ali NH; Malignant Hematology Department, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Sallman D; Malignant Hematology Department, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Padron E; Malignant Hematology Department, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
DeZern AE; Kimmel Cancer Center/Johns Hopkins University, Baltimore, MD, USA.
Barnard J; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.
Roboz GJ; Weill Cornell Medical College, New York, NY, USA.
Garcia-Manero G; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA.
List A; Malignant Hematology Department, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Steensma DP; Dana-Farber Cancer Institute, Boston, MA, USA.
Sekeres MA; Leukemia Program, Cleveland Clinic, Cleveland, OH, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2021 Jan; Vol. 10 (2), pp. 447-453. Date of Electronic Publication: 2020 Dec 22.
Typ publikacji:
Journal Article; Validation Study
MeSH Terms:
Response Evaluation Criteria in Solid Tumors*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Hematopoietic Stem Cell Transplantation/*mortality
Myelodysplastic Syndromes/*mortality
Aged ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Humans ; Male ; Myelodysplastic Syndromes/pathology ; Myelodysplastic Syndromes/therapy ; Remission Induction ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Establishing a Student Evaluation of Online Teaching and Learning Framework through Analysis of Existing Instruments
Autorzy:
Sun, Ting
Martin, Florence
Kim, Stella Y.
Westine, Carl
Pokaż więcej
Deskryptory:
Student Evaluation of Teacher Performance
Web Based Instruction
Instructional Effectiveness
Online Courses
College Students
In Person Learning
Technology Uses in Education
Evaluation Criteria
Źródło:
Online Learning. Mar 2023 27(1):356-382.
Recenzowane naukowo:
Y
Page Count:
27
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 10990

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies